Brown Brothers Harriman & Co’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,000
| Closed | -$9.72K | – | 1557 |
|
|
2024
Q3 | $9.72K | Hold |
3,000
| – | – | ﹤0.01% | 1058 |
|
|
2024
Q2 | $9K | Hold |
3,000
| – | – | ﹤0.01% | 981 |
|
|
2024
Q1 | $14K | Hold |
3,000
| – | – | ﹤0.01% | 945 |
|
|
2023
Q4 | $12.4K | Hold |
3,000
| – | – | ﹤0.01% | 919 |
|
|
2023
Q3 | $9K | Hold |
3,000
| – | – | ﹤0.01% | 967 |
|
|
2023
Q2 | $7.38K | Hold |
3,000
| – | – | ﹤0.01% | 1005 |
|
|
2023
Q1 | $6.78K | Hold |
3,000
| – | – | ﹤0.01% | 1029 |
|
|
2022
Q4 | $10.5K | Hold |
3,000
| – | – | ﹤0.01% | 1011 |
|
|
2022
Q3 | $111K | Hold |
3,000
| – | – | ﹤0.01% | 573 |
|
|
2022
Q2 | $57K | Hold |
3,000
| – | – | ﹤0.01% | 683 |
|
|
2022
Q1 | $81K | Sell |
3,000
-3,000
| -50% | -$81K | ﹤0.01% | 662 |
|
|
2021
Q4 | $135 | Hold |
6,000
| – | – | ﹤0.01% | 546 |
|
|
2021
Q3 | $157 | Hold |
6,000
| – | – | ﹤0.01% | 494 |
|
|
2021
Q2 | $192 | Hold |
6,000
| – | – | ﹤0.01% | 449 |
|
|
2021
Q1 | $211 | Hold |
6,000
| – | – | ﹤0.01% | 406 |
|
|
2020
Q4 | $192K | Hold |
6,000
| – | – | ﹤0.01% | 445 |
|
|
2020
Q3 | $226K | Hold |
6,000
| – | – | ﹤0.01% | 367 |
|
|
2020
Q2 | $269K | Hold |
6,000
| – | – | ﹤0.01% | 337 |
|
|
2020
Q1 | $205K | Hold |
6,000
| – | – | ﹤0.01% | 348 |
|
|
2019
Q4 | $234K | Buy |
+6,000
| New | +$234K | ﹤0.01% | 436 |
|